BioSilta

BioSilta Oy specializes in developing advanced growth systems for microbial cultures, primarily serving research laboratories and biotechnology companies. Operating in the life sciences market, BioSilta's core product, EnPresso B growth systems, leverages EnBase technology to control glucose supply and optimize microbial growth. This approach addresses common issues in conventional growth media, such as uncontrolled growth, harmful metabolite production, and oxygen depletion. By providing a controlled environment, BioSilta's systems enhance the yield and quality of recombinant proteins, which are crucial for various research applications. The business model revolves around selling these innovative growth systems, which are easy to use and integrate into existing lab workflows. Revenue is generated through direct sales to research institutions and biotech firms, as well as through partnerships with lab reagent suppliers.

Keywords: microbial cultures, recombinant proteins, EnBase technology, glucose control, research labs, biotechnology, growth systems, life sciences, lab reagents, high-yield.